270 related articles for article (PubMed ID: 8757343)
1. HIV-1 gp120-specific antibody-dependent cell-mediated cytotoxicity correlates with rate of disease progression.
Baum LL; Cassutt KJ; Knigge K; Khattri R; Margolick J; Rinaldo C; Kleeberger CA; Nishanian P; Henrard DR; Phair J
J Immunol; 1996 Sep; 157(5):2168-73. PubMed ID: 8757343
[TBL] [Abstract][Full Text] [Related]
2. Alterations in antibody-dependent cellular cytotoxicity during the course of HIV-1 infection. Humoral and cellular defects.
Tyler DS; Stanley SD; Nastala CA; Austin AA; Bartlett JA; Stine KC; Lyerly HK; Bolognesi DP; Weinhold KJ
J Immunol; 1990 May; 144(9):3375-84. PubMed ID: 2329275
[TBL] [Abstract][Full Text] [Related]
3. Saliva can mediate HIV-1-specific antibody-dependent cell-mediated cytotoxicity.
Kim JS; Nag P; Landay AL; Alves M; Cohn MH; Bremer JW; Baum LL
FEMS Immunol Med Microbiol; 2006 Nov; 48(2):267-73. PubMed ID: 16978244
[TBL] [Abstract][Full Text] [Related]
4. Temporal development and prognostic value of antibody response to the major neutralizing epitopes of gp120 during HIV-1 infection.
Turbica I; Simon F; Besnier JM; LeJeune B; Choutet P; Goudeau A; Barin F
J Med Virol; 1997 Jul; 52(3):309-15. PubMed ID: 9210041
[TBL] [Abstract][Full Text] [Related]
5. GP120 specific cellular cytotoxicity in HIV-1 seropositive individuals. Evidence for circulating CD16+ effector cells armed in vivo with cytophilic antibody.
Tyler DS; Nastala CL; Stanley SD; Matthews TJ; Lyerly HK; Bolognesi DP; Weinhold KJ
J Immunol; 1989 Feb; 142(4):1177-82. PubMed ID: 2536767
[TBL] [Abstract][Full Text] [Related]
6. Antibody-dependent cell-mediated cytotoxicity in cervical lavage fluids of human immunodeficiency virus type 1--infected women.
Battle-Miller K; Eby CA; Landay AL; Cohen MH; Sha BE; Baum LL
J Infect Dis; 2002 Feb; 185(4):439-47. PubMed ID: 11865395
[TBL] [Abstract][Full Text] [Related]
7. Comparison of antibodies that mediate HIV type 1 gp120 antibody-dependent cell-mediated cytotoxicity in asymptomatic HIV type 1-positive men and women.
Mata MM; Iwema JR; Dell S; Neems L; Jamieson BD; Phair J; Cohen MH; Anastos K; Baum LL
AIDS Res Hum Retroviruses; 2014 Jan; 30(1):50-7. PubMed ID: 23972002
[TBL] [Abstract][Full Text] [Related]
8. Serum and effector-cell antibody-dependent cellular cytotoxicity (ADCC) activity remains high during human immunodeficiency virus (HIV) disease progression.
Ojo-Amaize E; Nishanian PG; Heitjan DF; Rezai A; Esmail I; Korns E; Detels R; Fahey J; Giorgi JV
J Clin Immunol; 1989 Nov; 9(6):454-61. PubMed ID: 2576558
[TBL] [Abstract][Full Text] [Related]
9. Neutralization and enhancement of HIV-1 infection by sera from HIV-1 infected individuals who progress to disease at different rates.
Jolly PE; Weiss HL
Virology; 2000 Jul; 273(1):52-9. PubMed ID: 10891407
[TBL] [Abstract][Full Text] [Related]
10. Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells.
Rook AH; Lane HC; Folks T; McCoy S; Alter H; Fauci AS
J Immunol; 1987 Feb; 138(4):1064-7. PubMed ID: 3027168
[TBL] [Abstract][Full Text] [Related]
11. Neutralizing antibodies in relation to antibody-dependent cellular cytotoxicity-inducing antibodies against human immunodeficiency virus type I.
Böttiger B; Ljunggren K; Karlsson A; Krohn K; Fenyö EM; Jondal M; Biberfeld G
Clin Exp Immunol; 1988 Sep; 73(3):339-42. PubMed ID: 3208445
[TBL] [Abstract][Full Text] [Related]
12. Virologic and serologic markers of rapid progression to AIDS after HIV-1 seroconversion.
Farzadegan H; Henrard DR; Kleeberger CA; Schrager L; Kirby AJ; Saah AJ; Rinaldo CR; O'Gorman M; Detels R; Taylor E; Phair JP; Margolick JB
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Dec; 13(5):448-55. PubMed ID: 8970472
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive investigation of common antibody-dependent cell-mediated cytotoxicity antibody epitopes of HIV-1 CRF01_AE gp120.
Ampol S; Pattanapanyasat K; Sutthent R; Permpikul P; Kantakamalakul W
AIDS Res Hum Retroviruses; 2012 Oct; 28(10):1250-8. PubMed ID: 22288892
[TBL] [Abstract][Full Text] [Related]
14. Antibody-dependent cellular cytotoxicity-inducing antibodies against human immunodeficiency virus. Presence at different clinical stages.
Ljunggren K; Böttiger B; Biberfeld G; Karlson A; Fenyö EM; Jondal M
J Immunol; 1987 Oct; 139(7):2263-7. PubMed ID: 3498755
[TBL] [Abstract][Full Text] [Related]
15. Antibody-dependent cellular cytotoxicity against HIV-coated target cells by peripheral blood monocytes from HIV seropositive asymptomatic patients.
Jewett A; Giorgi JV; Bonavida B
J Immunol; 1990 Dec; 145(12):4065-71. PubMed ID: 2258607
[TBL] [Abstract][Full Text] [Related]
16. IgG subclass response to HIV in relation to antibody-dependent cellular cytotoxicity at different clinical stages.
Ljunggren K; Broliden PA; Morfeldt-Månson L; Jondal M; Wahren B
Clin Exp Immunol; 1988 Sep; 73(3):343-7. PubMed ID: 3208446
[TBL] [Abstract][Full Text] [Related]
17. Antibodies to the HIV-1 Tat protein correlated with nonprogression to AIDS: a rationale for the use of Tat toxoid as an HIV-1 vaccine.
Zagury JF; Sill A; Blattner W; Lachgar A; Le Buanec H; Richardson M; Rappaport J; Hendel H; Bizzini B; Gringeri A; Carcagno M; Criscuolo M; Burny A; Gallo RC; Zagury D
J Hum Virol; 1998; 1(4):282-92. PubMed ID: 10195253
[TBL] [Abstract][Full Text] [Related]
18. Antibody-dependent cell-mediated cytotoxicity: comparison between HTLV-I and HIV-1 assays.
Sinclair AL; Habeshaw JA; Muir L; Chandler P; Forster S; Cruickshank K; Dalgleish AG
AIDS; 1988 Dec; 2(6):465-72. PubMed ID: 3149493
[TBL] [Abstract][Full Text] [Related]
19. [Rapid and slow progression of the infection by the type 1 human immunodeficiency virus in a population of seropositive subjects in Madrid].
Soriano V; Martín R; del Romero J; Castilla J; Bru F; Bravo R; Gutiérrez M; Martínez P; Valencia E; García S; Mas A; Moreno V; Laguna F; Rodríguez C; Sabín ML; González-Lahoz J
Med Clin (Barc); 1996 Dec; 107(20):761-6. PubMed ID: 9019602
[TBL] [Abstract][Full Text] [Related]
20. Lymphokine-activated killer (LAK) cell anti-HIV-1 ADCC reactivity: a potential strategy for reduction of virus-infected cellular reservoirs.
Tyler DS; Stanley SD; Bartlett JA; Bolognesi DP; Weinhold KJ
J Surg Res; 1998 Oct; 79(2):115-20. PubMed ID: 9758725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
